Novonesis has now completed the announced share buyback program of B shares worth up to EUR 100 million (DKK 746 million) in total during 2025. As of June 27th, 2025, Novonesis has purchased an accumulated 1,729,099 shares with a transaction value of DKK 745,2 million under the share buyback program announced by Novonesis in Company announcement No. 3, 2025 and initiated on March 5, 2025.
Please read the full announcement in PDF.
Attachment
A202, a design-led innovation, is launched in an exclusive marketing arrangement with Zydus Lifesciences LimitedThe…
Group PerformanceRevenue: US$959.5 million, +61.4% year-on-yearGross profit: US$553.2 million, +103.3% year-on-yearAdjusted net profit: US$230.3 million,…
March 20, 2026 13:30 ET | Source: SANUWAVE Health, Inc. EDEN PRAIRIE, Minn., March 20,…
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 20 March 2026 – 6 PM CET Disclosure of…
KNOXVILLE, TN., March 20, 2026 (GLOBE NEWSWIRE) -- SafeSpace Global Corporation (OTCID: SSGC) (SafeSpace Global…
AGRA, India, March 20, 2026 /PRNewswire/ -- Hettich Poddar Woodworking Institute (HPWWI) has achieved a…